Unknown

Dataset Information

0

Hypericin maintians PDX1 expression via the Erk pathway and protects islet ?-cells against glucotoxicity and lipotoxicity.


ABSTRACT: A decrease in islet ?-cell mass is closely associated with the development and progression of diabetes. Therefore, protection against ?-cell loss is an essential measure to prevent and treat diabetes. In this study, we investigated the protective effects of non-photoactivated hypericin, a natural compound, on ?-cells both in vitro and in vivo. In vitro, hypericin greatly improved INS-1 cell viability under high-glucose and high-fatty-acid conditions by inhibiting glucotoxicity- and lipotoxicity-induced apoptosis and nitric oxide (NO) production. Then, we further demonstrated that hypericin elicited its protective effects against glucotoxicity and lipotoxicity in INS-1 cells by attenuating the reduction in pancreatic duodenal homeobox-1 (PDX1) expression and Erk activity. In vivo, prophylactic or therapeutic use of hypericin inhibited islet ?-cell apoptosis and enhanced the anti-oxidative ability of pancreatic tissue in high-fat/high-sucrose (HFHS)-fed mice, thus alleviating ?-cell loss and maintaining or improving ?-cell mass and islet size. More importantly, hypericin treatment decreased fasting blood glucose, improved glucose intolerance and insulin intolerance, and alleviated hyperinsulinaemia in HFHS-fed mice. Therefore, hypericin showed preventive and therapeutic effects against HFHS-induced onset of type II diabetes in mice. Hypericin possesses great potential for development as an anti-diabetes drug in the future.

SUBMITTER: Liang C 

PROVIDER: S-EPMC6643136 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hypericin maintians PDX1 expression via the Erk pathway and protects islet β-cells against glucotoxicity and lipotoxicity.

Liang Chen C   Hao Fang F   Yao Xinlei X   Qiu Ye Y   Liu Lei L   Wang Shuyue S   Yu Chunlei C   Song Zhenbo Z   Bao Yongli Y   Yi Jingwen J   Huang Yanxin Y   Wu Yin Y   Zheng Lihua L   Sun Ying Y   Wang Guannan G   Yang Xiaoguang X   Yang Shaonian S   Sun Luguo L   Li Yuxin Y  

International journal of biological sciences 20190602 7


A decrease in islet β-cell mass is closely associated with the development and progression of diabetes. Therefore, protection against β-cell loss is an essential measure to prevent and treat diabetes. In this study, we investigated the protective effects of non-photoactivated hypericin, a natural compound, on β-cells both <i>in vitro</i> and <i>in vivo</i>. <i>In vitro</i>, hypericin greatly improved INS-1 cell viability under high-glucose and high-fatty-acid conditions by inhibiting glucotoxici  ...[more]

Similar Datasets

| S-EPMC4655268 | biostudies-literature
| S-EPMC7489913 | biostudies-literature
| S-EPMC6668071 | biostudies-literature
| S-EPMC5136495 | biostudies-literature
| S-EPMC4488173 | biostudies-literature
| S-EPMC1748267 | biostudies-literature
| S-EPMC10993184 | biostudies-literature
| S-EPMC6946759 | biostudies-literature
| S-EPMC9040265 | biostudies-literature
| S-EPMC11022058 | biostudies-literature